Dr Lisa Philp, BSc(Biomedical Science), BSc(Hons), PhD(Medicine)
Position:
- Postdoctoral Research Fellow, Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology
Credentials:
- BSc(Biomedical Science), BSc(Hons), PhD(Medicine) at University of Adelaide
Websites:
Biography:
Dr Philp undertook studies for a Bachelor of Science (Biomedical Science) majoring in physiology and pharmacology, and a Bachelor of Science (Honours) at the University of Adelaide. She subsequently completed her PhD in Medicine at the University of Adelaide investigating the effect of diet and gender on obesity, body composition, and metabolism, under the supervision of Prof Gary Wittert, a leading endocrinologist and researcher with interests in obesity and men’s health.
Due to her strong interest in developing expertise in another critical aspect of men's health, namely, prostate cancer, Dr Philp joined the Adelaide Prostate Cancer Research Centre and worked as a postdoctoral research fellow under the supervision of A/Prof Lisa Butler and Prof Wayne Tilley. Here Dr Philp’s key research interest was in understanding the factors that influence prostate cancer initiation and progression and, as a result, she was involved with a team of researchers that generated a novel Gleason progression cohort and a series of tissue microarrays with the aim of studying prostate cancer progression. In addition, Dr Philp made a considerable contribution to the implementation and customisation of a new computerised image analysis system at the Adelaide Prostate Cancer Research Centre. She was also the chief researcher involved in characterising a novel mouse model of altered androgen action.
In October 2014, Dr Philp joined the research team at the Australian Prostate Cancer Research Centre - Queensland. Here she works as a postdoctoral research fellow under the supervision of Prof Colleen Nelson, Dr Jennifer Gunter and Dr Martin Sadowski and forms part of a team aiming to understand the metabolic adaptations observed in men undergoing prolonged androgen deprivation therapy for advanced prostate cancer.
Prostate cancer progression, Androgen receptor, Small glutamine-rich tetratricopeptide repeat-containing protein alpha, Tissue microarrays, Immunohistochemistry, Computerised image analysis, Mouse models.
